Universal (UVV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Nov, 2025Executive summary
Revenue increased 3% for the first half and 6% for the second quarter of fiscal 2026, driven by higher tobacco and ingredients sales volumes.
Net income attributable to shareholders rose 64% for the first half and 32% for the quarter, reflecting improved operating results and lower tax rates.
Both Tobacco and Ingredients segments delivered strong operational execution, with firm customer demand and effective management despite margin pressures from FX, product mix, and fixed costs.
Sustainability initiatives advanced, including increased use of clean electricity and investments in renewable energy at multiple sites.
Board leadership strengthened with the appointment of Gregory A. Trojan.
Financial highlights
First half consolidated revenue was $1.35 billion, up $40 million year-over-year; second quarter revenue was $754 million, up $43 million.
First half operating income rose $16 million to $102 million; second quarter operating income was $68 million, down $1 million due to FX, inventory write-downs, and provisions for farmer advances.
Net income attributable to shareholders was $42.7 million for the first half, up 64% year-over-year; diluted EPS was $1.70, up from $1.04.
Gross margin for the first half was 18.8%, up 50 bps year-over-year; second quarter margin was 18.5%, down 160 bps.
Net debt at September 30, 2025, was $1.07 billion, down $52 million year-over-year; net debt/net capitalization ratio improved to 42%.
Outlook and guidance
Customer demand for tobacco remains firm, but supply is expected to move to an oversupply position by fiscal year-end; management is confident in managing the shift.
Ingredients segment is well-positioned for future growth, focusing on organic expansion and new product development despite market and tariff headwinds.
Capital expenditures for the next twelve months are expected to be $45–$55 million, focused on maintenance and growth projects.
Uncommitted inventory expected to remain within target range for the full year.
Latest events from Universal
- Revenue and profit fell, but tobacco stayed strong and liquidity improved with new credit facility.UVV
Q3 20269 Feb 2026 - Q1 FY2025 revenue up 15% and operating income up 56%, with strong demand across segments.UVV
Q1 20252 Feb 2026 - Strategy centers on tobacco leadership, scaling ingredients, and sustainable, profitable growth.UVV
28th Annual ICR Conference 202613 Jan 2026 - Shareholders will vote on directors, executive pay, and auditor ratification amid strong results and ESG progress.UVV
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and strong ESG focus.UVV
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve pay, and ratify auditor, with updated proxy card.UVV
Proxy Filing1 Dec 2025 - Revenue up 7% to $2.95B, operating income up 5%, with strong segment growth and improved liquidity.UVV
Q4 202526 Nov 2025 - Operating income nearly doubled on strong tobacco margins, despite higher costs and tariff risks.UVV
Q1 202623 Nov 2025 - Digital-first growth, strong Asia expansion, and premium wellness products drive performance.UVV
Investor Presentation27 Jun 2025